| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $613.6M | +40.3% |
| R&D Expense | $74.4M | +11.4% |
| SG&A Expense | $222.4M | -20.1% |
| Operating Income | $20.1M | +115.6% |
| Pre-tax Income | $50.6M | +143.1% |
| Income Tax | $724K | +135.1% |
| Net Income | $28.1M | +142.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.9M | +48.7% |
| Accounts Receivable | $526K | -55.0% |
| Current Assets | $770.0M | +3.8% |
| Total Assets | $1.05B | +0.7% |
| Current Liabilities | $552.0M | +38.9% |
| Total Liabilities | $675.8M | +28.3% |
| Stockholders' Equity | $233.3M | -19.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $225.0M | +33.7% |
| Capital Expenditures | $25.6M | -18.5% |
| Investing Cash Flow | -$15.5M | +95.7% |
| Financing Cash Flow | -$216.0M | -342.0% |
| Free Cash Flow | $199.5M | +45.7% |